Pfizer just released data on an Respiratory Syncytial Virus (RSV) vaccine, after promising preliminary results on a maternal shot for newborns.

Pfizer says the vaccine is highly effective at protecting newborns when the shot is given to the mothers late in their pregnancy, according to clinical trial data published today.

RSV is a common respiratory virus that generally causes mild cold-like symptoms, but it can be dangerous for infants younger than 6 months.

RSV is the leading cause of child hospitalizations in this country.

This year's flu season is already shaping up to be an intense one. Flu-related hospitalizations are currently on the rise in all age groups, but especially in children.

The upward surge is happening considerably earlier than it has over the past decade, according to a new report from the Centers for Disease Control and Prevention.

So far, the CDC estimates that 880,000 people have been infected with the flu. Of that number, 6,900 have been hospitalized, and 360 have died.

The first flu-related pediatric death of the season was also reported this week.

Even more concerning for this year's flu season, fewer people have gotten flu shots at this point in the year than compared to 2021 and 2020, according to CDC data.

News 12's Elizabeth Hashagen was joined by Dr. Thomas McGinn to answer your health questions.